ROPEGINTERFERON ALFA-2B

ROPEGINTERFERON ALFA-2B was reported 1859 times

ROPEGINTERFERON ALFA-2B is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ADMINISTRATION SITE PHOTOSENSITIVITY REACTION 1 1.0000
1 VENIPUNCTURE 3 0.0698
2 INJECTION SITE PHOTOSENSITIVITY REACTION 1 0.0667
3 INJECTION SITE ALOPECIA 2 0.0455
4 AURICULAR HAEMATOMA 1 0.0435
5 NEUROLOGICAL EYELID DISORDER 1 0.0417
6 HAEMATOCRIT INCREASED 93 0.0408
7 PHLEBOTOMY 2 0.0263
8 AQUAGENIC PRURITUS 2 0.0244
9 IMMUNE-MEDIATED GASTROINTESTINAL DISORDER 1 0.0233
10 OESOPHAGEAL DYSPLASIA 1 0.0192
11 MONONUCLEOSIS HETEROPHILE TEST POSITIVE 1 0.0185
12 BORRELIA TEST POSITIVE 1 0.0167
13 HAEMATOCRIT ABNORMAL 20 0.0163
14 DYSMETROPSIA 1 0.0154
15 GARDNERELLA INFECTION 1 0.0145
16 BASOPHILIA 1 0.0133
17 APOPTOTIC COLONOPATHY 1 0.0120
18 GINGIVAL PRURITUS 1 0.0116
19 RED BLOOD CELL COUNT INCREASED 32 0.0116
20 BLOOD IMMUNOGLOBULIN M ABNORMAL 1 0.0097
21 AUTOIMMUNE THYROID DISORDER 1 0.0092
22 ANEURYSM REPAIR 1 0.0088
23 INTESTINAL BARRIER DYSFUNCTION 1 0.0086
24 ENZYME LEVEL DECREASED 1 0.0076
25 BASOPHIL COUNT DECREASED 2 0.0075
26 HEPATITIS C ANTIBODY POSITIVE 2 0.0074
27 ALBUMIN GLOBULIN RATIO INCREASED 1 0.0073
28 PLATELET COUNT INCREASED 91 0.0070
29 EXTRAMEDULLARY HAEMOPOIESIS 1 0.0063
30 MULTISYSTEM INFLAMMATORY SYNDROME 1 0.0058
31 DRUG RESISTANCE MUTATION 1 0.0056
32 MYELOFIBROSIS 17 0.0056
33 ORAL BACTERIAL INFECTION 1 0.0055
34 MUSCULOSKELETAL TOXICITY 1 0.0054
35 HEPATIC VASCULAR THROMBOSIS 1 0.0052
36 PERSISTENT DEPRESSIVE DISORDER 2 0.0050
37 AUTOINFLAMMATORY DISEASE 1 0.0047
38 CHOLELITHOTOMY 1 0.0046
39 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 2 0.0045
40 MILLER FISHER SYNDROME 1 0.0045
41 OPHTHALMIC MIGRAINE 3 0.0043
42 CEREBRAL MICROANGIOPATHY 1 0.0042
43 AUTOIMMUNE HYPOTHYROIDISM 1 0.0042
44 WRONG DOSE 10 0.0041
45 PRODUCT TEMPERATURE EXCURSION ISSUE 21 0.0041
46 PRODUCT DISTRIBUTION ISSUE 36 0.0039
47 EYELID CYST 1 0.0039
48 DEVICE USE CONFUSION 2 0.0038
49 ANTICIPATORY ANXIETY 1 0.0037
50 MORNING SICKNESS 2 0.0037
51 POLYCYTHAEMIA VERA 3 0.0037
52 DAIRY INTOLERANCE 1 0.0036
53 OESOPHAGEAL OEDEMA 1 0.0035
54 HAEMORRHAGIC ASCITES 1 0.0035
55 COLON DYSPLASIA 1 0.0035
56 CREUTZFELDT-JAKOB DISEASE 1 0.0035
57 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
58 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
59 ALLERGY TO VACCINE 1 0.0032
60 INCREASED DOSE ADMINISTERED 1 0.0032
61 PERIORAL DERMATITIS 2 0.0031
62 ALLERGY TO ARTHROPOD BITE 1 0.0031
63 CHALAZION 2 0.0031
64 OESTRADIOL DECREASED 1 0.0031
65 DOUBLE STRANDED DNA ANTIBODY POSITIVE 1 0.0031
66 METABOLIC FUNCTION TEST ABNORMAL 1 0.0030
67 MYELOPROLIFERATIVE NEOPLASM 2 0.0030
68 BLAST CELL CRISIS 1 0.0030
69 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
70 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
71 LIVER FUNCTION TEST DECREASED 1 0.0028
72 LOWER URINARY TRACT SYMPTOMS 1 0.0028
73 NONINFECTIVE GINGIVITIS 4 0.0028
74 RED BLOOD CELL COUNT ABNORMAL 4 0.0027
75 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
76 MEAN CELL VOLUME DECREASED 4 0.0026
77 ADMINISTRATION SITE REACTION 1 0.0026
78 SPLENECTOMY 3 0.0026
79 MUSCLE DISCOMFORT 2 0.0025
80 TACHYARRHYTHMIA 6 0.0024
81 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
82 DEVICE CONNECTION ISSUE 5 0.0024
83 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
84 NAIL BED DISORDER 1 0.0023
85 HAEMANGIOMA OF SKIN 1 0.0023
86 FUNGAL FOOT INFECTION 1 0.0023
87 BIOPSY BONE MARROW ABNORMAL 1 0.0022
88 MEAN CELL HAEMOGLOBIN DECREASED 4 0.0022
89 MANUFACTURING ISSUE 1 0.0022
90 THERAPEUTIC RESPONSE DELAYED 6 0.0021
91 MEAN CELL VOLUME ABNORMAL 1 0.0021
92 BLOOD IRON DECREASED 25 0.0021
93 INJECTION SITE DISCHARGE 11 0.0020
94 BRAIN FOG 31 0.0020
95 BREAST CONSERVING SURGERY 1 0.0020
96 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
97 NAIL RIDGING 1 0.0019
98 GINGIVAL DISCOLOURATION 1 0.0019
99 EPHELIDES 1 0.0019
100 HYPEREOSINOPHILIC SYNDROME 1 0.0018
101 COSTOCHONDRITIS 3 0.0018
102 LABORATORY TEST ABNORMAL 54 0.0018
103 POST PROCEDURAL SWELLING 2 0.0018
104 OCULAR TOXICITY 2 0.0018
105 CRYSTAL URINE PRESENT 1 0.0018
106 OESOPHAGEAL FOOD IMPACTION 1 0.0018
107 EYE INFECTION BACTERIAL 1 0.0018
108 ECZEMA EYELIDS 1 0.0018
109 BODY TINEA 1 0.0018
110 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
111 FULL BLOOD COUNT INCREASED 2 0.0017
112 LYMPHATIC DISORDER 1 0.0017
113 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
114 PLATELET COUNT ABNORMAL 10 0.0017
115 MONOCYTE COUNT DECREASED 2 0.0016
116 SPLENOMEGALY 19 0.0016
117 POST-ACUTE COVID-19 SYNDROME 2 0.0016
118 HAEMATOCRIT DECREASED 32 0.0016
119 MONOCYTOSIS 1 0.0016
120 ELBOW OPERATION 1 0.0016
121 IMPATIENCE 3 0.0016
122 MONOCLONAL GAMMOPATHY 1 0.0016
123 HYPERAESTHESIA TEETH 2 0.0016
124 ABORTION MISSED 2 0.0016
125 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
126 GINGIVAL RECESSION 3 0.0016
127 GINGIVAL DISCOMFORT 1 0.0015
128 EMBOLIC CEREBRAL INFARCTION 1 0.0015
129 HEAT ILLNESS 1 0.0015
130 TONGUE DRY 2 0.0015
131 FEELING OF RELAXATION 1 0.0015
132 CYTOKINE STORM 1 0.0015
133 IMMUNISATION REACTION 1 0.0014
134 BLOOD FOLATE DECREASED 1 0.0014
135 CYCLIC VOMITING SYNDROME 1 0.0014
136 INFLUENZA LIKE ILLNESS 111 0.0013
137 LIMB CRUSHING INJURY 1 0.0013
138 GINGIVAL ABSCESS 1 0.0013
139 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
140 OVARIAN NEOPLASM 1 0.0013
141 EAR DISORDER 6 0.0013
142 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
143 DEBRIDEMENT 1 0.0013
144 MYOPERICARDITIS 1 0.0013
145 BLOOD TEST ABNORMAL 18 0.0013
146 CARDIAC STRESS TEST ABNORMAL 1 0.0012
147 BRADYCARDIA FOETAL 1 0.0012
148 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 2 0.0012
149 DENTAL DISCOMFORT 1 0.0012
150 HEPATITIS A 1 0.0012
151 INFECTED BITE 1 0.0012
152 ENZYME LEVEL INCREASED 1 0.0012
153 LOWER RESPIRATORY TRACT CONGESTION 2 0.0012
154 DRUG DELIVERY SYSTEM MALFUNCTION 6 0.0012
155 ABNORMAL LOSS OF WEIGHT 8 0.0012
156 CRANIOFACIAL FRACTURE 1 0.0012
157 SERUM FERRITIN DECREASED 2 0.0012
158 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
159 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
160 HAEMOGLOBIN INCREASED 5 0.0011
161 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
162 BONE CONTUSION 1 0.0011
163 COLOUR BLINDNESS 1 0.0011
164 FOETAL HEART RATE ABNORMAL 1 0.0011
165 TRICHORRHEXIS 3 0.0011
166 BLOOD CHOLESTEROL DECREASED 2 0.0011
167 BLOOD IRON INCREASED 2 0.0011
168 NEUTROPHIL COUNT ABNORMAL 3 0.0011
169 PRODUCT AVAILABILITY ISSUE 24 0.0011
170 LIPOATROPHY 1 0.0011
171 MENOMETRORRHAGIA 2 0.0010
172 INJECTION SITE SCAB 1 0.0010
173 MOTION SICKNESS 2 0.0010
174 HYPERVIGILANCE 1 0.0010
175 NEEDLE ISSUE 30 0.0010
176 BLOOD IRON ABNORMAL 1 0.0010
177 DUODENAL PERFORATION 1 0.0010
178 GENE MUTATION 2 0.0010
179 HAEMANGIOMA OF LIVER 1 0.0010
180 ILEAL ULCER 1 0.0010
181 SUDDEN HEARING LOSS 2 0.0010
182 BRAIN STEM INFARCTION 1 0.0010
183 CAROTID ARTERIOSCLEROSIS 1 0.0010
184 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
185 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
186 SLEEP DEFICIT 2 0.0009
187 INJECTION SITE IRRITATION 12 0.0009
188 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
189 ACARODERMATITIS 1 0.0009
190 CARDIAC AMYLOIDOSIS 1 0.0009
191 INTENTIONAL DEVICE MISUSE 4 0.0009
192 BONE PAIN 52 0.0009
193 INJECTION SITE DISCOLOURATION 11 0.0009
194 ADMINISTRATION SITE PAIN 1 0.0009
195 DEPRESSION SUICIDAL 3 0.0009
196 CHRONIC SPONTANEOUS URTICARIA 1 0.0009
197 RENAL FUNCTION TEST ABNORMAL 4 0.0009
198 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
199 DEVICE DISPENSING ERROR 1 0.0008
200 HEPATIC ENZYME INCREASED 57 0.0008
201 BILE DUCT STENOSIS 1 0.0008
202 DYSPLASIA 1 0.0008
203 PULSE ABNORMAL 2 0.0008
204 HELICOBACTER GASTRITIS 1 0.0008
205 CARDIAC DYSFUNCTION 3 0.0008
206 RED BLOOD CELL COUNT DECREASED 23 0.0008
207 MEAN CELL VOLUME INCREASED 2 0.0008
208 EMOTIONAL DISORDER 24 0.0008
209 DRUG TITRATION ERROR 2 0.0008
210 DACRYOSTENOSIS ACQUIRED 1 0.0008
211 RETINAL DISORDER 2 0.0008
212 NAIL DISCOLOURATION 3 0.0008
213 FULL BLOOD COUNT ABNORMAL 8 0.0008
214 GINGIVAL PAIN 6 0.0008
215 ANIMAL BITE 2 0.0007
216 MACULAR HOLE 1 0.0007
217 NIGHT SWEATS 24 0.0007
218 MIGRAINE WITH AURA 2 0.0007
219 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
220 EFFUSION 1 0.0007
221 WHITE BLOOD CELL COUNT INCREASED 28 0.0007
222 INJECTION SITE EXTRAVASATION 9 0.0007
223 MACULE 2 0.0007
224 INSURANCE ISSUE 11 0.0007
225 ELECTRIC SHOCK SENSATION 2 0.0007
226 MUSCLE FATIGUE 3 0.0007
227 APPENDIX DISORDER 1 0.0007
228 CEREBRAL THROMBOSIS 2 0.0007
229 AUDITORY DISORDER 1 0.0007
230 GENITAL RASH 1 0.0007
231 NAIL INFECTION 1 0.0007
232 INVESTIGATION ABNORMAL 1 0.0007
233 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
234 FOOT AMPUTATION 1 0.0007
235 PANCREATIC ENZYMES INCREASED 1 0.0007
236 TOOTH DISCOLOURATION 2 0.0007
237 BLOOD CREATINE INCREASED 3 0.0007
238 BLOOD POTASSIUM INCREASED 11 0.0007
239 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
240 ANGIOPLASTY 1 0.0007
241 MENTAL FATIGUE 1 0.0007
242 IRON DEFICIENCY 3 0.0007
243 ORAL MUCOSAL EXFOLIATION 1 0.0007
244 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
245 INCREASED TENDENCY TO BRUISE 6 0.0007
246 INJECTION SITE PARAESTHESIA 1 0.0007
247 DAYDREAMING 1 0.0006
248 ROSACEA 3 0.0006
249 ONYCHOLYSIS 1 0.0006
250 BILE DUCT STONE 2 0.0006
251 FRUSTRATION TOLERANCE DECREASED 5 0.0006
252 PLATELET COUNT DECREASED 65 0.0006
253 BEDRIDDEN 8 0.0006
254 PAPILLOMA VIRAL INFECTION 1 0.0006
255 INJECTION RELATED REACTION 1 0.0006
256 LIVER FUNCTION TEST INCREASED 13 0.0006
257 ARTHROPOD STING 1 0.0006
258 MITRAL VALVE PROLAPSE 1 0.0006
259 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 107 0.0006
260 DEAFNESS BILATERAL 1 0.0006
261 SLUGGISHNESS 6 0.0006
262 INJECTION SITE OEDEMA 1 0.0006
263 MILIARIA 1 0.0006
264 LEFT VENTRICULAR FAILURE 2 0.0006
265 CHOREA 1 0.0006
266 BLOOD CHLORIDE INCREASED 1 0.0006
267 TACHYPHRENIA 2 0.0006
268 INJECTION SITE ERYTHEMA 70 0.0006
269 PRODUCT SUPPLY ISSUE 4 0.0006
270 THIRST 10 0.0006
271 GINGIVITIS 3 0.0006
272 DEPRESSED MOOD 29 0.0005
273 ESSENTIAL HYPERTENSION 1 0.0005
274 THROMBOCYTOSIS 2 0.0005
275 WHITE BLOOD CELL COUNT DECREASED 59 0.0005
276 OESOPHAGEAL SPASM 1 0.0005
277 DRY EYE 27 0.0005
278 DENTAL CARE 1 0.0005
279 TENDON INJURY 2 0.0005
280 ANGER 18 0.0005
281 PROTEIN TOTAL DECREASED 2 0.0005
282 AUTOIMMUNE THYROIDITIS 2 0.0005
283 PARANASAL SINUS DISCOMFORT 2 0.0005
284 DEVICE MALFUNCTION 37 0.0005
285 ARTERIAL DISORDER 1 0.0005
286 INJECTION SITE RASH 16 0.0005
287 THYROID MASS 2 0.0005
288 GINGIVAL DISORDER 2 0.0005
289 EARLY SATIETY 1 0.0005
290 NASAL SEPTUM DEVIATION 1 0.0005
291 MULTI-ORGAN DISORDER 1 0.0005
292 ENERGY INCREASED 3 0.0005
293 MUSCLE HAEMORRHAGE 2 0.0005
294 RESTLESS LEGS SYNDROME 9 0.0005
295 DERMATITIS ACNEIFORM 3 0.0005
296 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
297 DERMATITIS PSORIASIFORM 1 0.0005
298 HYPERSOMNIA 14 0.0005
299 ACCIDENTAL UNDERDOSE 7 0.0005
300 THYROID FUNCTION TEST ABNORMAL 2 0.0005
301 PERICARDITIS 8 0.0005
302 BUNDLE BRANCH BLOCK LEFT 2 0.0005
303 HEPATIC CYTOLYSIS 6 0.0005
304 TENSION HEADACHE 2 0.0005
305 POOR QUALITY SLEEP 10 0.0005
306 CARDIAC FLUTTER 3 0.0005
307 EXPOSURE VIA SKIN CONTACT 12 0.0005
308 TOOTH INJURY 2 0.0005
309 PRURITUS 177 0.0005
310 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
311 TONGUE DISCOLOURATION 2 0.0005
312 FATIGUE 355 0.0005
313 LIMB MASS 1 0.0005
314 THYROID DISORDER 7 0.0005
315 MIDDLE EAR EFFUSION 1 0.0005
316 ELECTROCARDIOGRAM T WAVE INVERSION 1 0.0005
317 DANDRUFF 1 0.0005
318 IRRITABILITY 27 0.0004
319 BACTERIAL TEST POSITIVE 1 0.0004
320 BLOOD LOSS ANAEMIA 1 0.0004
321 IMMUNE THROMBOCYTOPENIA 2 0.0004
322 ONYCHOCLASIS 3 0.0004
323 LICHEN PLANUS 1 0.0004
324 DISCOURAGEMENT 1 0.0004
325 ORAL SURGERY 1 0.0004
326 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
327 SARCOIDOSIS 2 0.0004
328 TONGUE DISORDER 3 0.0004
329 HYPERTHYROIDISM 6 0.0004
330 INCORRECT DOSAGE ADMINISTERED 2 0.0004
331 GLOMERULONEPHRITIS 1 0.0004
332 KNEE OPERATION 4 0.0004
333 TOOTH EXTRACTION 5 0.0004
334 PRODUCT DOSE OMISSION ISSUE 118 0.0004
335 HEPATIC ENZYME ABNORMAL 2 0.0004
336 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
337 HOSTILITY 1 0.0004
338 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
339 THERAPY INTERRUPTED 28 0.0004
340 LIPASE INCREASED 3 0.0004
341 EUPHORIC MOOD 4 0.0004
342 INITIAL INSOMNIA 4 0.0004
343 HEPATOSPLENOMEGALY 1 0.0004
344 INJECTION SITE BRUISING 31 0.0004
345 INTENTIONAL DOSE OMISSION 11 0.0004
346 GASTROINTESTINAL INFLAMMATION 3 0.0004
347 SERUM FERRITIN INCREASED 2 0.0004
348 FOOD POISONING 2 0.0004
349 BREAST SWELLING 1 0.0004
350 LARYNGOSPASM 1 0.0004
351 BRUXISM 2 0.0004
352 DRY MOUTH 30 0.0004
353 CHEILITIS 2 0.0004
354 HIP SURGERY 2 0.0004
355 ABDOMINAL RIGIDITY 1 0.0004
356 ANORGASMIA 1 0.0004
357 BACK INJURY 4 0.0004
358 MOOD ALTERED 10 0.0004
359 ABNORMAL DREAMS 10 0.0004
360 HAEMOGLOBIN DECREASED 37 0.0004
361 MYALGIA 61 0.0004
362 INTERMENSTRUAL BLEEDING 2 0.0004
363 MASS 5 0.0004
364 MALNUTRITION 4 0.0004
365 INJECTION SITE SCAR 1 0.0004
366 OFF LABEL USE 304 0.0003
367 EYELID MARGIN CRUSTING 1 0.0003
368 HYPERVENTILATION 2 0.0003
369 NECK INJURY 1 0.0003
370 INCORRECT DOSE ADMINISTERED 77 0.0003
371 MOUTH ULCERATION 7 0.0003
372 GANGRENE 2 0.0003
373 BONE MARROW DISORDER 1 0.0003
374 CRANIOCEREBRAL INJURY 1 0.0003
375 INJECTION SITE PRURITUS 22 0.0003
376 CYTOPENIA 4 0.0003
377 ALANINE AMINOTRANSFERASE INCREASED 20 0.0003
378 FIBROSIS 1 0.0003
379 MULTIPLE-DRUG RESISTANCE 1 0.0003
380 EYELIDS PRURITUS 1 0.0003
381 NASAL DRYNESS 2 0.0003
382 PHOTOPSIA 2 0.0003
383 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
384 BLADDER PAIN 1 0.0003
385 MOOD SWINGS 10 0.0003
386 HAEMOGLOBIN ABNORMAL 2 0.0003
387 SKIN ULCER 8 0.0003
388 AUTOIMMUNE DISORDER 3 0.0003
389 LIGAMENT SPRAIN 3 0.0003
390 NEAR DEATH EXPERIENCE 1 0.0003
391 APPETITE DISORDER 2 0.0003
392 ADVERSE DRUG REACTION 27 0.0003
393 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
394 LYME DISEASE 1 0.0003
395 CANDIDA INFECTION 5 0.0003
396 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
397 HEPATIC CYST 1 0.0003
398 FEELING HOT 18 0.0003
399 FEELING ABNORMAL 70 0.0003
400 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
401 HEPATIC FIBROSIS 1 0.0003
402 MUSCULOSKELETAL DISCOMFORT 5 0.0003
403 ALOPECIA 57 0.0003
404 MICTURITION DISORDER 1 0.0003
405 FORMICATION 2 0.0003
406 FEELING COLD 8 0.0003
407 RASH MACULAR 10 0.0003
408 EMBOLIC STROKE 1 0.0003
409 CONJUNCTIVAL HYPERAEMIA 1 0.0003
410 COVID-19 49 0.0003
411 VISUAL FIELD DEFECT 2 0.0003
412 LIVER TRANSPLANT 1 0.0003
413 FAECES SOFT 2 0.0003
414 ABDOMINAL DISCOMFORT 46 0.0003
415 APATHY 4 0.0003
416 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
417 CUTANEOUS VASCULITIS 1 0.0003
418 SENSITIVE SKIN 2 0.0003
419 AMYLASE INCREASED 1 0.0003
420 ARTHROPOD BITE 2 0.0003
421 OCULAR DISCOMFORT 3 0.0003
422 CHEMOTHERAPY 1 0.0003
423 STOMATITIS 16 0.0003
424 MICTURITION URGENCY 3 0.0003
425 MYOCARDITIS 3 0.0003
426 DISSOCIATION 2 0.0003
427 MUSCULOSKELETAL CHEST PAIN 4 0.0003
428 CONCUSSION 2 0.0003
429 APHTHOUS ULCER 2 0.0003
430 FAECES HARD 1 0.0003
431 THERAPY PARTIAL RESPONDER 4 0.0003
432 ORAL INFECTION 1 0.0003
433 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
434 AFFECTIVE DISORDER 2 0.0003
435 LYMPHADENOPATHY 9 0.0003
436 PRODUCT USE COMPLAINT 4 0.0003
437 SINUS DISORDER 5 0.0003
438 DEPRESSION 57 0.0003
439 HEADACHE 157 0.0003
440 BLOOD DISORDER 2 0.0002
441 BLEPHARITIS 1 0.0002
442 CONTUSION 24 0.0002
443 ARTERIOSPASM CORONARY 1 0.0002
444 INTRACRANIAL ANEURYSM 1 0.0002
445 OROPHARYNGEAL PAIN 23 0.0002
446 MYASTHENIA GRAVIS 2 0.0002
447 PRODUCT ADMINISTRATION ERROR 5 0.0002
448 NOCTURIA 3 0.0002
449 MUSCLE TIGHTNESS 4 0.0002
450 GOITRE 1 0.0002
451 INJECTION SITE WARMTH 5 0.0002
452 ARTHRALGIA 101 0.0002
453 LEG AMPUTATION 1 0.0002
454 GENERALISED OEDEMA 3 0.0002
455 EOSINOPHIL COUNT INCREASED 2 0.0002
456 TINNITUS 11 0.0002
457 INTERVERTEBRAL DISC DISORDER 1 0.0002
458 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
459 SKIN HYPERPIGMENTATION 2 0.0002
460 MELANOCYTIC NAEVUS 1 0.0002
461 BLOOD CALCIUM INCREASED 2 0.0002
462 ONYCHOMYCOSIS 1 0.0002
463 IMMUNE SYSTEM DISORDER 3 0.0002
464 PRODUCT COMMUNICATION ISSUE 2 0.0002
465 GINGIVAL SWELLING 1 0.0002
466 LUNG INFILTRATION 2 0.0002
467 CATHETERISATION CARDIAC 1 0.0002
468 EYE HAEMORRHAGE 3 0.0002
469 MALIGNANT MELANOMA 3 0.0002
470 THROAT IRRITATION 10 0.0002
471 CHILLS 26 0.0002
472 GASTROENTERITIS VIRAL 4 0.0002
473 OROPHARYNGEAL DISCOMFORT 2 0.0002
474 UVEITIS 3 0.0002
475 TOOTHACHE 4 0.0002
476 LUPUS-LIKE SYNDROME 2 0.0002
477 EXOSTOSIS 2 0.0002
478 SKIN LESION 6 0.0002
479 DISEASE COMPLICATION 1 0.0002
480 INSOMNIA 58 0.0002
481 DRUG INTOLERANCE 21 0.0002
482 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
483 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
484 ORAL DISCOMFORT 3 0.0002
485 INTERCEPTED MEDICATION ERROR 1 0.0002
486 DIARRHOEA HAEMORRHAGIC 2 0.0002
487 PRODUCT PACKAGING ISSUE 2 0.0002
488 GASTRIC ULCER 4 0.0002
489 GESTATIONAL DIABETES 1 0.0002
490 HYPERHIDROSIS 27 0.0002
491 LIMB OPERATION 1 0.0002
492 PARAESTHESIA ORAL 3 0.0002
493 LOCALISED INFECTION 5 0.0002
494 ERUCTATION 4 0.0002
495 NEURALGIA 5 0.0002
496 PRODUCT STORAGE ERROR 18 0.0002
497 AGITATION 15 0.0002
498 NASAL POLYPS 1 0.0002
499 NIGHTMARE 7 0.0002
500 FOOT OPERATION 1 0.0002
501 VISUAL IMPAIRMENT 25 0.0002
502 DEVICE USE ERROR 7 0.0002
503 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
504 BLOOD PRESSURE ABNORMAL 4 0.0002
505 ANEURYSM 1 0.0002
506 INJECTION SITE INFLAMMATION 1 0.0002
507 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
508 MIGRAINE 19 0.0002
509 LACRIMATION INCREASED 6 0.0002
510 FULL BLOOD COUNT DECREASED 4 0.0002
511 TASTE DISORDER 4 0.0002
512 CEREBRAL ISCHAEMIA 1 0.0002
513 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
514 FOETAL DEATH 1 0.0002
515 CRYING 7 0.0002
516 ACUTE MYELOID LEUKAEMIA 3 0.0002
517 PULMONARY HYPERTENSION 4 0.0002
518 TENDERNESS 2 0.0002
519 POLLAKIURIA 8 0.0002
520 MALABSORPTION 1 0.0002
521 SCIATICA 3 0.0002
522 HYPOTHYROIDISM 6 0.0002
523 NASAL CONGESTION 11 0.0002
524 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
525 ANAL FISSURE 1 0.0002
526 HOT FLUSH 14 0.0002
527 DECREASED ACTIVITY 2 0.0002
528 PHARYNGITIS STREPTOCOCCAL 2 0.0002
529 NORMAL NEWBORN 1 0.0002
530 MENTAL DISORDER 8 0.0002
531 OESOPHAGITIS 2 0.0002
532 GASTROINTESTINAL PAIN 2 0.0002
533 DEAFNESS UNILATERAL 1 0.0002
534 DIVERTICULITIS 5 0.0002
535 LIVER DISORDER 8 0.0002
536 NECK PAIN 10 0.0002
537 PULMONARY OEDEMA 8 0.0002
538 ANGIOPATHY 1 0.0002
539 ANAEMIA 34 0.0002
540 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
541 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
542 EYE INFECTION 2 0.0002
543 EXPOSURE DURING PREGNANCY 11 0.0002
544 NEUTROPHILIA 1 0.0002
545 ANXIETY 50 0.0002
546 CHOLECYSTECTOMY 2 0.0002
547 ATRIAL FIBRILLATION 17 0.0002
548 EXERCISE TOLERANCE DECREASED 1 0.0002
549 BLOOD URIC ACID INCREASED 1 0.0002
550 SYRINGE ISSUE 3 0.0002
551 HYPERTRIGLYCERIDAEMIA 1 0.0002
552 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
553 LYMPHOCYTE COUNT DECREASED 3 0.0002
554 DECREASED INTEREST 1 0.0002
555 PAIN 104 0.0002
556 DIZZINESS 84 0.0002
557 NASOPHARYNGITIS 31 0.0002
558 ODYNOPHAGIA 1 0.0002
559 ACCIDENT 2 0.0002
560 GASTROINTESTINAL DISORDER 15 0.0002
561 GOUT 3 0.0002
562 POLYNEUROPATHY 2 0.0002
563 DISTURBANCE IN ATTENTION 9 0.0002
564 INJECTION SITE VESICLES 1 0.0002
565 PELVIC PAIN 3 0.0002
566 FOETAL GROWTH RESTRICTION 1 0.0002
567 SMALL INTESTINAL OBSTRUCTION 2 0.0002
568 BLOOD GLUCOSE ABNORMAL 3 0.0002
569 CONJUNCTIVITIS 3 0.0002
570 DIARRHOEA 104 0.0002
571 HEPATIC STEATOSIS 3 0.0002
572 HEPATIC CIRRHOSIS 3 0.0002
573 PHOTOPHOBIA 3 0.0002
574 BLOOD SODIUM DECREASED 3 0.0002
575 BLEPHAROSPASM 1 0.0002
576 UNEVALUABLE EVENT 12 0.0002
577 BRAIN OEDEMA 2 0.0002
578 COLITIS 6 0.0002
579 ACNE 12 0.0002
580 MUSCULOSKELETAL DISORDER 3 0.0002
581 SLEEP APNOEA SYNDROME 3 0.0002
582 ASTHENIA 59 0.0002
583 ENTERITIS 1 0.0002
584 SLEEP DISORDER 11 0.0002
585 DECREASED APPETITE 36 0.0002
586 INJECTION SITE INDURATION 2 0.0002
587 HEPATITIS ACUTE 1 0.0002
588 ORAL HERPES 3 0.0002
589 ABDOMINAL DISTENSION 16 0.0002
590 NODULE 2 0.0002
591 BRADYPHRENIA 1 0.0002
592 ARTHRITIS 12 0.0002
593 SKIN DISCOLOURATION 7 0.0002
594 IMPAIRED HEALING 5 0.0002
595 ORAL CANDIDIASIS 2 0.0002
596 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
597 ADVERSE REACTION 2 0.0002
598 EAR INFECTION 4 0.0002
599 DRY SKIN 20 0.0001
600 HAIR TEXTURE ABNORMAL 2 0.0001
601 BREAST MASS 1 0.0001
602 BRONCHITIS 11 0.0001
603 SINUS CONGESTION 2 0.0001
604 GINGIVAL BLEEDING 2 0.0001
605 BLOOD TESTOSTERONE DECREASED 1 0.0001
606 NEPHROTIC SYNDROME 1 0.0001
607 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
608 JOINT EFFUSION 1 0.0001
609 CARPAL TUNNEL SYNDROME 2 0.0001
610 DEFAECATION URGENCY 1 0.0001
611 BURNING SENSATION 10 0.0001
612 LYMPHOPENIA 2 0.0001
613 SEASONAL ALLERGY 2 0.0001
614 HAND FRACTURE 1 0.0001
615 FEAR OF INJECTION 1 0.0001
616 PARAESTHESIA 22 0.0001
617 SKIN CANCER 3 0.0001
618 IMPAIRED QUALITY OF LIFE 2 0.0001
619 LETHARGY 8 0.0001
620 NAUSEA 110 0.0001
621 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
622 INTENTIONAL UNDERDOSE 1 0.0001
623 MAJOR DEPRESSION 1 0.0001
624 MOUTH HAEMORRHAGE 1 0.0001
625 ABDOMINAL PAIN UPPER 28 0.0001
626 PAIN IN EXTREMITY 40 0.0001
627 RASH 59 0.0001
628 CEREBRAL DISORDER 1 0.0001
629 TOOTH DISORDER 3 0.0001
630 FEELING DRUNK 1 0.0001
631 INFLUENZA 15 0.0001
632 COLON CANCER 2 0.0001
633 ECZEMA 7 0.0001
634 SNEEZING 3 0.0001
635 BREAST TENDERNESS 1 0.0001
636 URTICARIA 22 0.0001
637 VISION BLURRED 18 0.0001
638 MUSCLE SPASMS 24 0.0001
639 PYREXIA 45 0.0001
640 PERICARDIAL EFFUSION 3 0.0001
641 FOOD ALLERGY 1 0.0001
642 URINARY TRACT INFECTION 22 0.0001
643 WEIGHT DECREASED 36 0.0001
644 HYPOALBUMINAEMIA 1 0.0001
645 DEVICE INFORMATION OUTPUT ISSUE 1 0.0001
646 BASAL CELL CARCINOMA 2 0.0001
647 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
648 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
649 SINUSITIS 13 0.0001
650 FURUNCLE 1 0.0001
651 RESPIRATORY TRACT CONGESTION 2 0.0001
652 ABSCESS 2 0.0001
653 ATRIAL FLUTTER 1 0.0001
654 BACK PAIN 29 0.0001
655 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
656 BACK DISORDER 2 0.0001
657 DECUBITUS ULCER 1 0.0001
658 NEUTROPHIL COUNT DECREASED 5 0.0001
659 ABNORMAL FAECES 1 0.0001
660 CONDITION AGGRAVATED 37 0.0001
661 HEART RATE INCREASED 12 0.0001
662 MENSTRUAL DISORDER 1 0.0001
663 ACUTE CORONARY SYNDROME 1 0.0001
664 MUSCLE INJURY 1 0.0001
665 EPISTAXIS 9 0.0001
666 DEHYDRATION 16 0.0001
667 SKIN DISORDER 4 0.0001
668 SOMNOLENCE 24 0.0001
669 EYE PRURITUS 4 0.0001
670 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
671 HAEMATEMESIS 3 0.0001
672 CATARACT 7 0.0001
673 INJECTION SITE SWELLING 9 0.0001
674 FACIAL PARALYSIS 1 0.0001
675 ERECTILE DYSFUNCTION 3 0.0001
676 INJECTION SITE REACTION 8 0.0001
677 ANURIA 1 0.0001
678 BLOOD MAGNESIUM DECREASED 1 0.0001
679 ILL-DEFINED DISORDER 7 0.0001
680 VERTIGO 7 0.0001
681 DEAFNESS 3 0.0001
682 MUSCULAR WEAKNESS 13 0.0001
683 DEVICE USE ISSUE 2 0.0001
684 NAIL DISORDER 1 0.0001
685 INTENTIONAL PRODUCT MISUSE 10 0.0001
686 GALLBLADDER DISORDER 2 0.0001
687 FACIAL PAIN 1 0.0001
688 THROMBOSIS 9 0.0001
689 MYOSITIS 1 0.0001
690 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
691 PAIN OF SKIN 3 0.0001
692 BLOOD PRESSURE INCREASED 17 0.0001
693 ANAL INCONTINENCE 1 0.0001
694 HEAVY MENSTRUAL BLEEDING 1 0.0001
695 BLOOD BILIRUBIN INCREASED 3 0.0001
696 RASH PRURITIC 6 0.0001
697 LIMB INJURY 3 0.0001
698 PANIC ATTACK 4 0.0001
699 MALAISE 48 0.0001
700 NERVE COMPRESSION 1 0.0001
701 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
702 CHEST PAIN 20 0.0001
703 DYSGEUSIA 8 0.0001
704 INJECTION SITE PAIN 33 0.0001
705 HAEMOPTYSIS 3 0.0001
706 CHEST DISCOMFORT 11 0.0001
707 THINKING ABNORMAL 2 0.0001
708 WOUND 3 0.0001
709 RENAL DISORDER 5 0.0001
710 BLOOD CHOLESTEROL INCREASED 5 0.0001
711 NEPHROPATHY 1 0.0001
712 ILLNESS 11 0.0001
713 FLANK PAIN 1 0.0001
714 ABORTION INDUCED 1 0.0001
715 LEUKAEMIA 1 0.0001
716 PAIN IN JAW 3 0.0001
717 FLATULENCE 6 0.0001
718 FOOT FRACTURE 2 0.0001
719 PROTEINURIA 2 0.0001
720 FEELING JITTERY 2 0.0001
721 EYE INFLAMMATION 1 0.0001
722 PRODUCTIVE COUGH 5 0.0001
723 INCREASED APPETITE 2 0.0001
724 CHOLESTASIS 2 0.0001
725 POST PROCEDURAL COMPLICATION 2 0.0001
726 PERIPHERAL SWELLING 16 0.0001
727 ATELECTASIS 1 0.0001
728 EAR PAIN 2 0.0001
729 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
730 DYSPHONIA 6 0.0001
731 HAEMORRHOIDS 2 0.0001
732 SKIN FISSURES 2 0.0001
733 COELIAC DISEASE 1 0.0001
734 KIDNEY INFECTION 2 0.0001
735 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
736 HEPATOMEGALY 1 0.0001
737 ACUTE MYOCARDIAL INFARCTION 3 0.0001
738 DYSPEPSIA 10 0.0001
739 OVARIAN CYST 1 0.0001
740 BLOOD POTASSIUM DECREASED 3 0.0001
741 PROSTATE CANCER 8 0.0001
742 PRODUCT PHYSICAL ISSUE 2 0.0001
743 DRY THROAT 1 0.0001
744 FLUSHING 10 0.0001
745 DISCOMFORT 6 0.0001
746 NEUTROPHIL COUNT INCREASED 1 0.0001
747 EAR DISCOMFORT 1 0.0001
748 PRODUCT PREPARATION ERROR 2 0.0001
749 RIB FRACTURE 2 0.0001
750 LIMB DISCOMFORT 3 0.0001
751 TREMOR 16 0.0001
752 INJECTION SITE DISCOMFORT 1 0.0001
753 HEAD INJURY 3 0.0001
754 INCONTINENCE 1 0.0001
755 JOINT DISLOCATION 1 0.0001
756 OSTEOARTHRITIS 4 0.0001
757 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
758 IMPAIRED WORK ABILITY 2 0.0001
759 HYPOAESTHESIA 14 0.0001
760 PRODUCT PRESCRIBING ISSUE 2 0.0001
761 CHOLELITHIASIS 3 0.0001
762 MUSCULOSKELETAL STIFFNESS 8 0.0001
763 EYE DISORDER 3 0.0001
764 INJECTION SITE NODULE 1 0.0001
765 ANGIOEDEMA 4 0.0001
766 DENTAL CARIES 1 0.0001
767 VIRAL INFECTION 3 0.0001
768 LIP SWELLING 3 0.0001
769 TRANSAMINASES INCREASED 2 0.0001
770 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
771 GLOSSODYNIA 2 0.0001
772 ORAL PAIN 2 0.0001
773 RASH PAPULAR 2 0.0001
774 COUGH 25 0.0001
775 BLISTER 5 0.0001
776 OXYGEN SATURATION DECREASED 5 0.0001
777 DERMATITIS CONTACT 1 0.0001
778 ERYTHEMA 18 0.0001
779 NEPHROLITHIASIS 4 0.0001
780 CONSTIPATION 19 0.0001
781 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
782 METASTASES TO LUNG 1 0.0001
783 ABDOMINAL PAIN 20 0.0001
784 CAESAREAN SECTION 1 0.0001
785 HYPERKALAEMIA 3 0.0001
786 CARDIAC DISORDER 8 0.0001
787 SWELLING 8 0.0001
788 PALPITATIONS 10 0.0001
789 SURGERY 5 0.0001
790 MYOCLONUS 1 0.0001
791 MENTAL IMPAIRMENT 2 0.0001
792 PRESYNCOPE 2 0.0001
793 ACCIDENTAL OVERDOSE 3 0.0001
794 RESTLESSNESS 3 0.0001
795 INJECTION SITE URTICARIA 2 0.0001
796 CYST 1 0.0001
797 HEPATIC FUNCTION ABNORMAL 3 0.0001
798 DYSPNOEA EXERTIONAL 3 0.0001
799 CELLULITIS 4 0.0001
800 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
801 CARDIOVASCULAR DISORDER 2 0.0001
802 HYPOPHAGIA 2 0.0001
803 INFLAMMATION 4 0.0001
804 RHINORRHOEA 5 0.0001
805 NO ADVERSE EVENT 14 0.0001
806 HIATUS HERNIA 1 0.0001
807 DEEP VEIN THROMBOSIS 5 0.0001
808 BLOOD CREATININE INCREASED 5 0.0001
809 PSORIASIS 10 0.0001
810 NERVOUSNESS 4 0.0001
811 ADVERSE EVENT 7 0.0001
812 DISORIENTATION 3 0.0001
813 MENSTRUATION IRREGULAR 2 0.0001
814 PALLOR 2 0.0001
815 IMPAIRED GASTRIC EMPTYING 1 0.0001
816 CORONARY ARTERY OCCLUSION 1 0.0001
817 CARDIAC ARREST 6 0.0001
818 MENTAL STATUS CHANGES 2 0.0001
819 HUNGER 1 0.0001
820 APHONIA 1 0.0001
821 BLINDNESS UNILATERAL 1 0.0001
822 EYE PAIN 4 0.0001
823 LOSS OF CONSCIOUSNESS 9 0.0001
824 BRONCHOSPASM 1 0.0001
825 SKIN BURNING SENSATION 5 0.0001
826 PANCREATIC CARCINOMA 2 0.0001
827 MYELODYSPLASTIC SYNDROME 1 0.0001
828 FALL 23 0.0001
829 INJECTION SITE HAEMATOMA 1 0.0001
830 LIVER FUNCTION TEST ABNORMAL 2 0.0001
831 GASTROENTERITIS 1 0.0001
832 UNDERDOSE 5 0.0001
833 CONFUSIONAL STATE 11 0.0001
834 CARDIOMYOPATHY 1 0.0001
835 DYSPNOEA 38 0.0001
836 HAEMORRHAGE INTRACRANIAL 1 0.0001
837 HYPOAESTHESIA ORAL 1 0.0001
838 MEMORY IMPAIRMENT 9 0.0001
839 EPILEPSY 2 0.0001
840 HYPERSENSITIVITY 12 0.0001
841 DELUSION 1 0.0001
842 DRUG-INDUCED LIVER INJURY 2 0.0001
843 ARRHYTHMIA 3 0.0001
844 PULMONARY EMBOLISM 6 0.0001
845 NEUROPATHY PERIPHERAL 6 0.0001
846 RASH ERYTHEMATOUS 3 0.0001
847 BLOOD GLUCOSE DECREASED 3 0.0001
848 MANIA 1 0.0001
849 FUNGAL INFECTION 2 0.0001
850 URINARY RETENTION 2 0.0001
851 HEMIPARESIS 1 0.0001
852 FLUID RETENTION 3 0.0001
853 THERAPY CESSATION 3 0.0001
854 WEIGHT INCREASED 13 0.0001
855 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
856 HEART RATE DECREASED 2 0.0001
857 COLD SWEAT 1 0.0001
858 HYPERTENSION 12 0.0001
859 BRADYCARDIA 3 0.0001
860 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
861 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
862 DRUG ERUPTION 1 0.0001
863 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
864 CEREBRAL HAEMORRHAGE 2 0.0001
865 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
866 LEUKOCYTOSIS 1 0.0001
867 C-REACTIVE PROTEIN INCREASED 2 0.0001
868 TREATMENT NONCOMPLIANCE 3 0.0001
869 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
870 ASTHMA 6 0.0001
871 INTESTINAL OBSTRUCTION 2 0.0001
872 PNEUMONIA 17 0.0001
873 HERPES ZOSTER 3 0.0001
874 EYE IRRITATION 3 0.0001
875 SEIZURE 6 0.0001
876 NEUTROPENIA 7 0.0001
877 ABORTION SPONTANEOUS 2 0.0000
878 BODY TEMPERATURE INCREASED 1 0.0000
879 VOMITING 23 0.0000
880 BLOOD GLUCOSE INCREASED 9 0.0000
881 DERMATITIS 1 0.0000
882 KNEE ARTHROPLASTY 1 0.0000
883 CEREBROVASCULAR ACCIDENT 8 0.0000
884 EATING DISORDER 1 0.0000
885 JOINT INJURY 1 0.0000
886 RECTAL HAEMORRHAGE 2 0.0000
887 BALANCE DISORDER 4 0.0000
888 DEVICE LEAKAGE 2 0.0000
889 AMNESIA 3 0.0000
890 SWELLING FACE 3 0.0000
891 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
892 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
893 TACHYCARDIA 4 0.0000
894 HEPATOTOXICITY 1 0.0000
895 COLITIS ULCERATIVE 2 0.0000
896 THERAPY NON-RESPONDER 2 0.0000
897 CHROMATURIA 1 0.0000
898 PRODUCT QUALITY ISSUE 6 0.0000
899 DRUG INTERACTION 7 0.0000
900 SUICIDAL IDEATION 4 0.0000
901 SKIN IRRITATION 2 0.0000
902 DRUG INEFFECTIVE 57 0.0000
903 COGNITIVE DISORDER 2 0.0000
904 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
905 DISEASE PROGRESSION 5 0.0000
906 GAIT DISTURBANCE 8 0.0000
907 BLOOD PRESSURE FLUCTUATION 1 0.0000
908 INFECTION 6 0.0000
909 FIBROMYALGIA 1 0.0000
910 CEREBRAL INFARCTION 1 0.0000
911 LUNG DISORDER 2 0.0000
912 LIVER INJURY 1 0.0000
913 ABDOMINAL PAIN LOWER 1 0.0000
914 DRUG RESISTANCE 1 0.0000
915 HAEMATOMA 1 0.0000
916 DIPLOPIA 1 0.0000
917 MUCOSAL INFLAMMATION 1 0.0000
918 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
919 JOINT STIFFNESS 1 0.0000
920 ANHEDONIA 1 0.0000
921 PANCREATITIS 2 0.0000
922 INJECTION SITE HAEMORRHAGE 3 0.0000
923 CARDIAC FAILURE 3 0.0000
924 PRODUCT USE ISSUE 7 0.0000
925 FEAR 1 0.0000
926 JAUNDICE 1 0.0000
927 OEDEMA 2 0.0000
928 ARTHROPATHY 2 0.0000
929 MEDICATION ERROR 2 0.0000
930 PANCYTOPENIA 2 0.0000
931 THROMBOCYTOPENIA 4 0.0000
932 RENAL IMPAIRMENT 3 0.0000
933 SKIN EXFOLIATION 3 0.0000
934 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
935 ANGINA PECTORIS 1 0.0000
936 HYPOTENSION 7 0.0000
937 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
938 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
939 DYSSTASIA 1 0.0000
940 ASCITES 1 0.0000
941 DEVICE ISSUE 3 0.0000
942 JOINT SWELLING 4 0.0000
943 APHASIA 1 0.0000
944 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
945 PLEURAL EFFUSION 2 0.0000
946 GYNAECOMASTIA 1 0.0000
947 NERVOUS SYSTEM DISORDER 1 0.0000
948 BONE DENSITY DECREASED 1 0.0000
949 DYSPHAGIA 3 0.0000
950 CYSTITIS 1 0.0000
951 MOVEMENT DISORDER 1 0.0000
952 HIP FRACTURE 1 0.0000
953 BLOOD PRESSURE DECREASED 2 0.0000
954 GAIT INABILITY 1 0.0000
955 GASTRIC DISORDER 1 0.0000
956 MOBILITY DECREASED 2 0.0000
957 DYSURIA 1 0.0000
958 EYE SWELLING 1 0.0000
959 HALLUCINATION 2 0.0000
960 DRUG DOSE OMISSION BY DEVICE 2 0.0000
961 DEVICE BREAKAGE 1 0.0000
962 OEDEMA PERIPHERAL 3 0.0000
963 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
964 LUNG NEOPLASM MALIGNANT 1 0.0000
965 OSTEOPOROSIS 1 0.0000
966 CARDIO-RESPIRATORY ARREST 1 0.0000
967 MYOCARDIAL INFARCTION 4 0.0000
968 RENAL FAILURE 3 0.0000
969 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
970 OCULAR HYPERAEMIA 1 0.0000
971 MULTIPLE SCLEROSIS 1 0.0000
972 INTERSTITIAL LUNG DISEASE 1 0.0000
973 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
974 HAEMORRHAGE 2 0.0000
975 MUSCULOSKELETAL PAIN 1 0.0000
976 DERMATITIS ATOPIC 1 0.0000
977 HAEMATOCHEZIA 1 0.0000
978 HYPONATRAEMIA 1 0.0000
979 RHEUMATOID ARTHRITIS 2 0.0000
980 DEATH 14 0.0000
981 DEVICE DIFFICULT TO USE 1 0.0000
982 HOSPITALISATION 2 0.0000
983 CARDIAC FAILURE CONGESTIVE 1 0.0000
984 TOXICITY TO VARIOUS AGENTS 2 0.0000
985 DRUG WITHDRAWAL SYNDROME 1 0.0000
986 BREAST CANCER 1 0.0000
987 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
988 ACUTE KIDNEY INJURY 1 0.0000